Skip to content
Parakho

Aurobindo Pharma Ltd

NSE AUROPHARMABSE 524804aurobindo.comInvestor relations

Q1 FY27, unaudited

Revenue
₹2,799.51 Cr
Profit after tax
₹737.22 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations2,799.51−1.71%11,171.72
Other income241.89+188.75%587.53
Total income3,041.40+3.73%11,759.25
Employee benefit expense295.91+4.57%1,161.15
Finance costs47.07−21.55%213.15
Depreciation & amortisation68.99−1.47%285.36
Total expenses2,033.32−6.81%8,578.29
Profit before tax1,008.08+34.39%3,163.58
Tax expense270.86+41.84%748.78
Profit after tax737.22+31.85%2,414.80
Total comprehensive income737.49+32.21%2,415.88
Earnings per share
Earnings per share, basic₹12.75₹41.58
Earnings per share, diluted₹12.75₹41.58

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — unaudited, from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Aurobindo Pharma reported FY26 revenue of ₹33,653 crores and EBITDA of ₹6,856 crores, both described as highest-ever, with Q4 FY26 revenue at ₹8,853 crores and EBITDA at ₹1,801 crores. Management highlighted growth across formulations, API, Europe and growth markets, alongside progress on the Pen-G backward integration, biosimilars pipeline and the TheraNym CDMO project. Executives also discussed the Lannett acquisition timeline, US business growth plans and cost pressures from power, fuel and raw material inputs.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 85 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 25 Aug 2026.